Authors: Ossege, LM Sindern, E Patzold, T Malin, JP

Citation: Lm. Ossege et al., Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis, INT IMMUNO, 1(6), 2001, pp. 1085-1100

Authors: Sindern, E Niederkinkhaus, Y Henschel, M Ossege, LM Patzold, T Malin, JP

Citation: E. Sindern et al., Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis, ACT NEUR SC, 104(2), 2001, pp. 88-91

Authors: Ossege, LM Sindern, E Voss, B Malin, JP

Citation: Lm. Ossege et al., Expression of TNF alpha and TGF beta 1 in Guillain-Barre syndrome: correlation of a low TNF alpha-/TGF beta 1-mRNA ratio with good recovery and signsfor immunoregulation within the cerebrospinal fluid compartment, EUR J NEUR, 7(1), 2000, pp. 17-25

Authors: Ossege, LM Postler, E Pleger, B Muller, KM Malin, JP

Citation: Lm. Ossege et al., Neoplastic cells in the cerebrospinal fluid in intravascular lymphomatosis, J NEUROL, 247(8), 2000, pp. 656-658

Authors: Ossege, LM Sindern, E Voss, B Malin, JP

Citation: Lm. Ossege et al., Immunomodulatory effects of IFN beta-1b on the mRNA-expression of TGF beta-1 and TNF alpha in vitro, IMMUNOPHARM, 43(1), 1999, pp. 39-46

Authors: Ossege, LM Sindern, E Patzold, T Malin, JP

Citation: Lm. Ossege et al., Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta 1 and its receptor type II, J NEUROIMM, 91(1-2), 1998, pp. 73-81